The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Bio-Techne stock jumps, with Germany’s Merck KGaA buying the company at a 24% premium.

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more ...

The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...

Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...

Bio-Techne Corp, has agreed to an acquisition offer by Germany’s Merck KGaA for about $11.3 billion, the largest M&A deal ...

Merck KGaA has agreed to acquire Bio-Techne (NasdaqGS:TECH) for $11.5b in an all cash deal. Bio-Techne's board has ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...

Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...